Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

Age, race, income level, obesity, and physical inactivity all contribute to the risk of being diagnosed with diabetes.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Advances in AI have allowed researchers to use a short audio clip to detect diabetes with 66 percent accuracy in women and 71 ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

A small new study suggests that time-restricted eating could help improve blood sugar control in some people, thus ...

According to a study a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson disease ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

The FDA warned that batches of Terrafina brand raisins were recalled due to undeclared sulfites, which may cause ...